HB 880 – Maryland

Status: In Process
Year Introduced: 2024
Link: https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0880?ys=2024RS

This bill amends the reimbursement levels for drug products that the Maryland Medical Assistance Program (a state-funded health insurance program for low-income residents) is required to establish. This also applies to pharmacy benefit managers that contract with a pharmacy on behalf of a managed care organization. The reimbursement level will be at least equal to the national average drug acquisition cost of the generic product plus the fee-for-service professional dispensing fee. The bill also broadens the definition of a “purchaser” in laws regulating pharmacy benefits managers to include certain insurers, nonprofit health service plans, and health maintenance organizations.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found